USA contract research firm PPD says its global central laboratory operations in Beijing, China, has earned accreditation by the College of American Pathologists, making it the company's third central lab to meet the highest standard of excellence in enhancing patient safety and speeding drug development.
The CAP Laboratory Accreditation Program is an internationally-recognized program using rigorous accreditation standards to help laboratories advance the quality of laboratory services to improve patient care. The program uses multi-disciplinary teams of practicing lab professionals as inspectors who assess management and operations of laboratories, extending beyond regulatory requirements.
"Earning CAP accreditation at our Beijing partner lab validates our commitment to deliver high-quality, reliable data to our clients in a high-growth region for global clinical research," said Steve Lobel, vice president of PPD's global central laboratory operations.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze